Bioequivalence study results

Bioequivalence study results for Cyto-Protectin MR

Bioequivalence according to EMA (European Medicine Agency) standards.

Mean trimetazidine concentrations in blood serum after single dosage of Cyto-Protectin MR and Preductal MR in fasting state.

Mean trimetazidine concentrations in blood serum after single dosage of Cyto-Protectin MR and Preductal MR in fasting state.

Mean trimetazidine concentrations in blood serum after multiple dosage of Cyto-Protectin MR and Preductal MR in steady state.

Mean trimetazidine concentrations in blood serum after multiple dosage of Cyto-Protectin MR and Preductal MR in steady state.

Mean trimetazidine concentrations in blood serum after single dosage of Cyto-Protectin MR and Preductal MR in fed state.

Mean trimetazidine concentrations in blood serum after single dosage of Cyto-Protectin MR and Preductal MR in fed state.

AUC value in individual stages of bioequivalence study of Cyto-Protectin in comparison with reference drug (geometric mean ± SD)

AUC value in individual stages of bioequivalence study of Cyto-Protectin in comparison with reference drug (geometric mean ± SD)

On the basis of: "Modele badań równoważności biologicznej na przykładzie trimetazydyny" Anna Kamińska, Jacek Owczarek, Irena Wejman, Daria Orszulak- Michalak, Zakład Biofarmacji, Katedra Biofarmacji Uniwersytetu Medycznego w Łodzi; Farmacja Polska, tom 65, nr 11/2009 str. 761-764.